InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
T+90 hit rate
50%
T+90 mean return
-9.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Kauffman Michael, Director. Officer active across 4 companies, notably Kezar Life Sciences, Inc.. Cumulatively, 9 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €229k. Activity tracked since 3 January 2022. The latest transaction was disclosed on 21 November 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kauffman Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
8,550 shares@ US$10.00100.0% of flowCommon StockSEC:0001104659-25-116060:0
8,333 shares0Common StockSEC:0001104659-25-053096:0
8,333 shares0Common StockSEC:0001104659-24-073606:0
5,900 shares0Common StockSEC:0000950170-24-070605:0
5,900 shares0Common StockSEC:0001209191-23-033959:0
21,000 shares0Common StockSEC:0001209191-22-014624:0
9,079 shares@ US$12.12340.056% mcap45.4% of flowCommon StockSEC:0001209191-22-011636:0
6,764 shares@ US$9.8620.034% mcap27.3% of flowCommon StockSEC:0001209191-22-008124:0
5,000 shares@ US$5.910.048% mcap50.0% of flowCommon StockSEC:0001209191-22-001964:0
9 of 9 declarations
About Kauffman Michael
Michael Kauffman serves as a Director at Kezar Life Sciences, Inc. and Karyopharm Therapeutics Inc. In these roles, he participates in the governance of these companies and the formulation of strategies to promote innovation in the life sciences sector. His experience in the biopharmaceutical field is a valuable asset for the boards. He is committed to supporting research and the development of new therapies.
